Cover Kidney News
Volume/Issue:
Volume 14: Issue 1
Page:
21
Publication Date:
01 Jan 2022
Online Publication Date:
10 Jan 2022
  • 1.

    van de Logt A-E, et al. The anti-PLA2R antibody in membranous nephropathy: What we know and what remains a decade after its discovery. Kidney Int 2019;67 10.1016/j.kint.2019.07.014

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 2.

    Kestilä M, et al. Positionally cloned gene for a novel glomerular protein—nephrin—is mutated in congenital nephrotic syndrome. Mol Cell 1998; 1:575–582. doi: 10.1016/s1097-2765(00)80057-x

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 3.

    Watts A, et al. Discovery of autoantibodies targeting nephrin in minimal change disease supports a novel autoimmune etiology. J Am Soc Nephrol [published online ahead of print November 3, 2021]. doi: 10.1681/ASN.2021060794; https://jasn.asnjournals.org/content/early/2021/11/03/ASN.2021060794

    • PubMed
    • Search Google Scholar
    • Export Citation
Editorial Type:
Special Section

A Novel Non-invasive Biomarker for Minimal Change Disease: Will Anti-nephrin Antibodies Be the Next Anti-PLA2R?

Mayuri Trivedi Mayuri Trivedi, DM, is Assistant Professor with the Department of Nephrology, Lokmanya Tilak Medical General Hospital, Mumbai, India. Kirk N. Campbell is Professor of Medicine/Nephrology at the Icahn School of Medicine at Mount Sinai, New York, NY.

Search for other papers by Mayuri Trivedi in
Current site
Google Scholar
PubMed Close
and
Kirk N. Campbell Mayuri Trivedi, DM, is Assistant Professor with the Department of Nephrology, Lokmanya Tilak Medical General Hospital, Mumbai, India. Kirk N. Campbell is Professor of Medicine/Nephrology at the Icahn School of Medicine at Mount Sinai, New York, NY.

Search for other papers by Kirk N. Campbell in
Current site
Google Scholar
PubMed Close
Volume/Issue:
Volume 14: Issue 1
Publication Date:
01 Jan 2022
Page:
21
Restricted access
Save